Neopharma
Neopharma is a privately held global pharmaceutical company founded in 2003, operating across more than ten therapeutic areas with a focus on novel therapeutics. It employs 5,001-10,000 staff and serves international pharmaceutical markets.
- Company typePrivate
- Founded2003
- HeadquartersBristol, United States
- Headcount5,001–10,000
- GTM typeB2B
- OfferingHardware or Manufacturing
What Neopharma does
Neopharma is a privately held pharmaceutical company founded in 2003, headquartered in Bristol, United States, with 5,001-10,000 employees. The company self-describes as a global pharmaceutical provider operating across more than ten therapeutic areas, with an explicit strategic emphasis on novel therapeutics rather than purely generic or commodity products.
The company's offering spans branded and novel pharmaceutical products distributed across multiple therapeutic categories and international markets. No specific product list, pipeline assets, manufacturing footprint details, technology platform, or proprietary R&D assets are disclosed in the available input data, which constrains a more granular technical description. The website content available for analysis was a loading/verification placeholder and yielded no product-, pipeline-, or technology-level information.
The business model is consistent with a diversified mid-to-large pharmaceutical manufacturer: revenue is generated through the sale of pharmaceutical products across multiple therapeutic areas to a mix of institutional buyers, wholesalers, and healthcare providers across global markets. No pricing model, customer segmentation, distribution channel, partnership, marketing, or revenue mechanics are disclosed in the input. The company remains private, with no funding rounds, ownership structure, or investor information available, limiting further inference about capitalization and shareholder composition.
Neopharma firmographics
Firmographics- Name
- Neopharma
- Website
- https://neopharma.com
- Company type
- Private
- Founded year
- 2003
- Headcount range
- 5,001–10,000 employees
- Short description
- Neopharma is a privately held global pharmaceutical company founded in 2003, operating across more than ten therapeutic areas with a focus on novel therapeutics. It employs 5,001-10,000 staff and serves international pharmaceutical markets.
- Ownership category
- akta.pro rank
Neopharma industry classification
Industry- Product category
- Pharmaceutical Manufacturing
- NAICS
- Pharmaceutical and Medicine Manufacturing (3254), Pharmaceutical Preparation Manufacturing (325412)
- SIC
- Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Specialty Care Pharmaceuticals (HLAIAAAB)
- akta.pro secondary industries
- Primary Care & General Medicine Pharmaceuticals (HLAIAAAA), Specialty Injectable & Infusion Therapies (Cross-therapeutic) (HLAIACAO)
Keywords
Where Neopharma is headquartered
LocationHeadquarters
- HQ city
- Bristol
- HQ country
- United States
- HQ region
- North America
Markets served
Neopharma business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Personnel, Technology or R&D, Operations, Marketing or Sales
Neopharma product offering
Product offeringCore offering
Neopharma manufactures and supplies high-quality pharmaceutical products across more than ten therapeutic areas on a global basis. Its portfolio combines established products with a focus on novel therapeutics, indicating both commercial-scale manufacturing and an innovation-driven development pipeline serving healthcare markets worldwide.
Differentiator
Problem solved
Functional benefit
Companies that use Neopharma
Customer profileIdeal customer profiles1 record
Neopharma technology and API
TechnologyAPI detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Neopharma partnerships and signals
Strategic signalExpansion highlights2 records
Neopharma competitors and assessment
Company assessmentDirect peers
- Dr. Reddy's Laboratories: Global pharmaceutical company producing generics, biosimilars, and proprietary formulations across multiple therapeutic areas. Comparable to Neopharma on a broad multi-area portfolio, novel/branded formulations focus, and global commercial footprint.
- Torrent Pharmaceuticals: Indian global pharmaceutical company with branded and generics offerings concentrated in cardiovascular, CNS, and other chronic therapy areas. Comparable to Neopharma on multi-therapeutic branded-generic operations and global commercial scale.
- Strides Pharma Science: Indian-listed global pharmaceutical manufacturer focused on finished dosage forms across niche therapeutic areas with regulated-market distribution. Comparable to Neopharma on global pharma manufacturing and multi-therapeutic area branded-generic operations.
- Cipla: Indian-headquartered global pharmaceutical company manufacturing branded and generic medicines across multiple therapeutic areas including respiratory, cardiovascular, and CNS. Directly comparable to Neopharma on diversified multi-therapeutic portfolio and global distribution scale.
- Glenmark Pharmaceuticals: Global pharmaceutical company focused on branded generics, specialty, and innovation across dermatology, respiratory, and oncology. Comparable to Neopharma on a mid-sized, multi-therapeutic-area branded pharma profile with R&D emphasis.
- Aurobindo Pharma: Vertically integrated global pharmaceutical manufacturer offering APIs and finished dosage forms across multiple therapeutic categories including anti-infectives, cardiovascular, and CNS. Directly comparable to Neopharma on diversified branded and generic pharma manufacturing at global scale.
- Lupin Limited: Indian global pharmaceutical company with branded and generic offerings across cardiovascular, diabetology, respiratory, and other therapeutic areas. Peer to Neopharma in multi-therapeutic branded-generic pharma with global distribution.
Broad incumbents
- Sun Pharmaceutical Industries: One of the largest specialty and generic pharmaceutical companies globally, with a broad portfolio spanning multiple therapeutic areas including dermatology, neurology, and oncology. Comparable to Neopharma on broad therapeutic coverage but larger scale and more established specialty franchises.
- Mankind Pharma: Large Indian pharmaceutical company with a broad portfolio across multiple therapeutic categories and significant emerging-market presence. Comparable to Neopharma on multi-therapeutic area pharma footprint and scale of operations.
Regional players
- Julphar (Gulf Pharmaceutical Industries): UAE-headquartered pharmaceutical manufacturer producing branded generics across multiple therapeutic areas for regional markets. Adjacent peer to Neopharma in Mid-East presence and multi-therapeutic branded generic manufacturing.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat4 records
Key risks5 records
Key highlights5 records
Customer concentration
Neopharma social profiles
Digital presenceNeopharma financial estimates
Financial estimateRevenue estimate
Valuation estimate
Neopharma leadership team
Management profileNumber of profiles
Neopharma funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Neopharma M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Neopharma
What does Neopharma do?
Neopharma manufactures and supplies high-quality pharmaceutical products across more than ten therapeutic areas on a global basis. Its portfolio combines established products with a focus on novel therapeutics, indicating both commercial-scale manufacturing and an innovation-driven development pipeline serving healthcare markets worldwide.
When was Neopharma founded?
Neopharma was founded in 2003. It employs 5,001 to 10,000 people.
Where is Neopharma based?
Neopharma is headquartered in Bristol, United States, in the North America region.
Who are Neopharma's main competitors?
Direct peers on record are Dr. Reddy's Laboratories, Torrent Pharmaceuticals, Strides Pharma Science, Cipla, Glenmark Pharmaceuticals, Aurobindo Pharma and Lupin Limited. Broad incumbents are Sun Pharmaceutical Industries and Mankind Pharma. Julphar (Gulf Pharmaceutical Industries) is listed as a regional player.
Does Neopharma have an API?
No public API is recorded for Neopharma.
What industry is Neopharma in?
Neopharma's product category is Pharmaceutical Manufacturing. Its primary akta.pro industry code is HLAIAAAB, Specialty Care Pharmaceuticals, with a secondary code of HLAIAAAA, Primary Care & General Medicine Pharmaceuticals. Its NAICS code is 3254 and its SIC code is 2834.